The
California
Peptide Club
The Schelling Point on the Peptide Science Frontier.
The California Peptide Club is a community for physicians, researchers, founders, and the peptide-curious to educate on the science, protocols, and risks around peptides.
As covered in
I.Our Work
Gatherings
IRL gatherings at technology hubs like AGI House and DeSciNYC unite otherwise fragmented industry experts for panel discussions and breakout groups.
Education
The “Peptides 101” series lifts the veil and educates on the science, risks, protocols, industry players, commercial opportunities, and open research areas.
II.Why Peptides
The case for peptide adoption.
Peptide adoption raises both the floor and the ceiling: We can combat metabolic disease and unburden the healthcare system, and also achieve peak performance, recovery, looks, and health.
The industry is getting demystified. The FDA is weighing which peptides compounding pharmacies may keep making, GLP-1s have moved into everyday medicine, and questions that used to live in anonymous forums now get asked out loud, by physicians, researchers, and builders.
We’re supporting initiatives that bring clarity into the efficacy and safety of popular peptides through proteomic blood tests and studies.
We care about the future of personalized health. We're not a wellness group.
III.Our Long-Term Mission
We are building for peptide science what Florence was for the Renaissance and Bell Labs was for the information age.
Now we're taking it one step further and bringing it to a global level.
We are creating the infrastructure layer for regenerative medicine, one that enables effective research, AI-enabled drug discovery, clinical trial recruiting, education and media, and purposeful capital allocation.
To a decade of personalized medicine,
IV.Speakers
Our members and speakers have built unicorns, discovered bioregulators, scaled proteomic blood testing, educated hundreds of thousands on peptide science, healed chronic disease, and pioneered new delivery and manufacturing methods.
V.In the Press & Publications
Why Peptides Will Eat Your Lunch
How pharma engineers peptides to survive the stomach, why a quarter of users quit within a year, and why the answer might be algae or chocolate.
Semaglutide for Obesity Management: A Narrative Review of Efficacy, Safety, and Future Directions
What semaglutide does for weight, where the safety signals sit, and where the field is heading.
Peptides 101: What the Most Popular Peptides Do (and Where to Get Them)
A primer on the questions people ask most: what peptides are, which ones are safe, and how they get used.
The Quest for Oral GLP-1s
Three in four people say they would rather take a daily pill than a weekly shot. So why are there so few oral options?
Could Universal GLP-1 Drugs End the Obesity Epidemic?
What the studies say about broad GLP-1 access, and why it might even save households money.
See all Articles, Podcasts, and Media →
Every piece of writing, research and long-form conversation from our speakers, in one place.
VI.Resources
VII.Gatherings
United States
Europe
Active chapter
Past
VIII.Membership
Admission is by application. We look for people who bring something to the room, whether that is clinical experience, research, an operating company, or honest curiosity, and who want to build this field with us.
Apply to Join